Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM) Q3 2023 Earnings Conference Call November 7, 2023 8:00 AM ET

Company Participants

David Connolly - Executive Director, IR and Corporate Communications

David Meeker - Chairman, President, and CEO

Jennifer Chien - EVP, Head of North America

Yann Mazabraud - EVP, Head of International

Hunter Smith - CFO

Conference Call Participants

Corinne Jenkins - Goldman Sachs

Phil Nadeau - TD Cowen

Derek Archila - Wells Fargo

Dae Gon Ha - Stifel

Jeff Hung - Morgan Stanley

Whitney Ijem - Canaccord Genuity

Joseph Stringer - Needham

Operator

Good day and thank you for standing by. Welcome to the Rhythm Pharmaceuticals' Third Quarter 2023 Earnings Conference Call. At this time, all participants are in a listen-only mode. After the speakers' presentation, there will be a question-and-answer session. [Operator Instructions] Please be advised that today's conference is being recorded.

I would now like to hand the conference over to your speaker today, David Connolly, Executive Director of Investor Relations and Corporate Communications. Please go ahead.

David Connolly

Thank you, Victor. I'm Dave Connolly, here at Rhythm Pharmaceuticals. For those of you participating on the conference call, our slides can be accessed and controlled by going to the Investors section on the Investors page of our website at ir.rhythmtx.com. This morning, we issued a press release that provides our third quarter 2023 financial results and a business update, which is available on our website.

As listed on Slide 2, here with me today in Boston are David Meeker, Chair, Chief Executive Officer, and President of Rhythm Pharmaceuticals; Jennifer Chien, Executive Vice President, Head of North America; Hunter Smith, our Chief Financial Officer; and Yann Mazabraud, Executive Vice President, Head of International is on the line joining us from Europe.

And on Slide 3, I’ll remind you that this call contains remarks concerning future expectations, plans, and prospects, which constitute forward-looking statements. Actual results may differ materially from those indicated by these forward-looking statements as a result of various important factors, including those discussed in our most recent annual or quarterly reports on file with the SEC.

In addition, any forward-looking statements represents our views only as of today and should not be relied upon as presenting our views as of any subsequent date. We specifically disclaim any obligation to update such statements.

With that, I'll turn the call over to David Meeker, who will begin on Slide 5.

David Meeker